In the highly competitive market for inflammatory diseases such as Crohn’s, pharma companies are looking for ways to maximise benefits of already approved drugs, as well as developing new ones.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,